Clinical trials, data sharing and outcome measurement

Chairs: 

Jonathan Baets with Filippo Genovese

Keynote Talk:

  • 9:00 PL4-K: Wolfgang Pernice (Columbia University, Irving Medical Center, USA)
    DANCER: a new collaborative tool for ultra-scalable patient-partnered tracking of disease state and progression in CMT

Selected presentations:

  • 9:30 PL4-01: Connor Maltby (Ulysses Neuroscience Ltd., Ireland)
    Acetylated α-Tubulin as a clinical plasma biomarker of disease severity in CMT1A (abstract in pdf, 226 kb)
  • 9:43 PL4-02: Michael Shy (University of Iowa, USA)
    Charcot-Marie-Tooth disease type 1E: Clinical Natural History and Molecular Impact of PMP22 Variants (abstract in pdf, 243 kb)
  • 9:56 PL4-03: Marion Masingue (Pitié-Salpêtrière University Hospital, France, France)
    A COA8 homozygous mutation presenting as a demyelinating CMT with leukopathy (abstract in pdf, 226 kb)
  • 10:09 PL4-04: Alessandro Bertini (Istituto Neurologico C Besta, Italy)
    Genotype-phenotype correlation in a large cohort with HSPB1-related neuropathy (abstract in pdf, 236 kb)